| Clonal evolution in breast cancer revealed by single nucleus genome sequencing Y Wang, J Waters, ML Leung, A Unruh, W Roh, X Shi, K Chen, P Scheet, ... Nature 512 (7513), 155-160, 2014 | 1173 | 2014 |
| Dynamics of chronic myeloid leukaemia F Michor, TP Hughes, Y Iwasa, S Branford, NP Shah, CL Sawyers, ... Nature 435 (7046), 1267-1270, 2005 | 999 | 2005 |
| The mathematics of cancer: integrating quantitative models PM Altrock, LL Liu, F Michor Nature Reviews Cancer 15 (12), 730-745, 2015 | 732 | 2015 |
| Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity A Marusyk, DP Tabassum, PM Altrock, V Almendro, F Michor, K Polyak Nature 514 (7520), 54-58, 2014 | 656 | 2014 |
| Dynamics of cancer progression F Michor, Y Iwasa, MA Nowak Nature reviews cancer 4 (3), 197-205, 2004 | 638 | 2004 |
| Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling J Chmielecki, J Foo, GR Oxnard, K Hutchinson, K Ohashi, R Somwar, ... Science translational medicine 3 (90), 90ra59-90ra59, 2011 | 598 | 2011 |
| Studying clonal dynamics in response to cancer therapy using high-complexity barcoding HC Bhang, DA Ruddy, V Krishnamurthy Radhakrishna, JX Caushi, ... Nature medicine 21 (5), 440-448, 2015 | 550 | 2015 |
| Epidermal growth factor receptor tyrosine kinase inhibitor–resistant disease K Ohashi, YE Maruvka, F Michor, W Pao Journal of Clinical Oncology 31 (8), 1070-1080, 2013 | 535 | 2013 |
| Punctuated copy number evolution and clonal stasis in triple-negative breast cancer R Gao, A Davis, TO McDonald, E Sei, X Shi, Y Wang, PC Tsai, ... Nature genetics 48 (10), 1119-1130, 2016 | 496 | 2016 |
| Polyploidy can drive rapid adaptation in yeast AM Selmecki, YE Maruvka, PA Richmond, M Guillet, N Shoresh, ... Nature 519 (7543), 349-352, 2015 | 481 | 2015 |
| Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies H Haeno, M Gonen, MB Davis, JM Herman, CA Iacobuzio-Donahue, ... Cell 148 (1), 362-375, 2012 | 481 | 2012 |
| Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma CJ Gibson, RC Lindsley, V Tchekmedyian, BG Mar, J Shi, S Jaiswal, ... Journal of Clinical Oncology 35 (14), 1598-1605, 2017 | 439 | 2017 |
| Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ... Cancer cell 26 (2), 288-300, 2014 | 439 | 2014 |
| A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia A Klinakis, C Lobry, O Abdel-Wahab, P Oh, H Haeno, S Buonamici, ... Nature 473 (7346), 230-233, 2011 | 437 | 2011 |
| Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq M Karaayvaz, S Cristea, SM Gillespie, AP Patel, R Mylvaganam, CC Luo, ... Nature communications 9 (1), 3588, 2018 | 422 | 2018 |
| Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype SY Park, M Gönen, HJ Kim, F Michor, K Polyak The Journal of clinical investigation 120 (2), 636-644, 2010 | 392 | 2010 |
| Synergy and discounting of cooperation in social dilemmas C Hauert, F Michor, MA Nowak, M Doebeli Journal of theoretical biology 239 (2), 195-202, 2006 | 368 | 2006 |
| Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity V Almendro, YK Cheng, A Randles, S Itzkovitz, A Marusyk, E Ametller, ... Cell reports 6 (3), 514-527, 2014 | 322 | 2014 |
| JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response M Kleppe, M Kwak, P Koppikar, M Riester, M Keller, L Bastian, T Hricik, ... Cancer discovery 5 (3), 316-331, 2015 | 318* | 2015 |
| Successful therapy must eradicate cancer stem cells D Dingli, F Michor Stem cells 24 (12), 2603-2610, 2006 | 313 | 2006 |
